Stress-Dose Corticosteroid Versus Placebo in Neonatal Cardiac Operations: A Randomized Controlled Trial  Pertti K. Suominen, MD, PhD, Juho Keski-Nisula,

Slides:



Advertisements
Similar presentations
Stress-Dose Corticosteroid Versus Placebo in Neonatal Cardiac Operations: A Randomized Controlled Trial  Pertti K. Suominen, MD, PhD, Juho Keski-Nisula,
Advertisements

Antithrombin Administration in Patients With Low Antithrombin Values After Cardiac Surgery: A Randomized Controlled Trial  Domenico Paparella, MD, Crescenzia.
Serum C-Reactive Protein as a Predictor of Morbidity and Mortality in Intensive Care Unit Patients After Esophagectomy  Michel E. van Genderen, BS, Alexandre.
Major Bleeding, Transfusions, and Anemia: The Deadly Triad of Cardiac Surgery  Marco Ranucci, MD, FESC, Ekaterina Baryshnikova, BD, Serenella Castelvecchio,
Cumulative Corticosteroid Exposure and Infection Risk After Complex Pediatric Cardiac Surgery  Christopher W. Mastropietro, MD, Renee Barrett, MD, Maria.
Risk Index for Postoperative Acute Kidney Injury After Valvular Surgery Using Cardiopulmonary Bypass  Takashi Yamauchi, MD, PhD, Shigeru Miyagawa, MD,
Effect of a Single Bolus of Erythropoietin on Renoprotection in Patients Undergoing Thoracic Aortic Surgery With Moderate Hypothermic Circulatory Arrest 
The Myocardial Protective Effects of a Moderate-Potassium Blood Cardioplegia in Pediatric Cardiac Surgery: A Randomized Controlled Trial  Yang Liu, MD,
Risk-Adjusted Prolonged Length of Stay as an Alternative Outcome Measure for Pediatric Congenital Cardiac Surgery  Ming Liu, MS, MA, Charlotte M. Druschel,
Association of Perioperative Fluid Balance and Adverse Surgical Outcomes in Esophageal Cancer and Esophagogastric Junction Cancer  Shenhai Wei, MD, PhD,
A Closed Perfusion System With Heparin Coating and Centrifugal Pump Improves Cardiopulmonary Bypass Biocompatibility in Elderly Patients  Lena Lindholm,
Robert J Cerfolio, MD, Cyndi Bass, MSN, Charles R Katholi, PhD 
Warfarin Cessation Before Cardiopulmonary Bypass: Lessons Learned from a Randomized Controlled Trial of Oral Vitamin K  Richard P. Whitlock, MD, Mark.
Amr Mohammad Allama, MD  The Annals of Thoracic Surgery 
Does Diabetes Affect the Postoperative Outcomes After Total Arterial Off-Pump Coronary Bypass Surgery in Multivessel Disease?  Jae-Sung Choi, MD, PhD,
Cerebrospinal Fluid Markers of Brain Injury, Inflammation, and Blood-Brain Barrier Dysfunction in Cardiac Surgery  Björn Reinsfelt, MD, PhD, Sven-Erik.
James L Zellner, MD, Scott B Kribbs, BS, B
Bashir M Matata, PhD, Andrzej W Sosnowski, MD, Manuel Galiñanes 
Leukocyte depletion during cardiac operation: a new approach through the venous bypass circuit  Y.John Gu, MD, PhD, A.J de Vries, MD, Paulien Vos, Piet.
N-terminal B-type natriuretic peptide levels in pediatric patients with congestive heart failure undergoing cardiac surgery  Rowan Walsh, MD, Clark Boyer,
Sivelestat Attenuates Lung Injury in Surgery for Congenital Heart Disease With Pulmonary Hypertension  Norikazu Nomura, MD, PhD, Miki Asano, MD, PhD,
Metabolic and Hemodynamic Effects of High-Dose Insulin Treatment in Aortic Valve and Coronary Surgery  Juha K. Koskenkari, MD, Päivi K. Kaukoranta, MD,
Total Liquid Ventilation Reduces Lung Injury in Piglets After Cardiopulmonary Bypass  Lijun Jiang, MD, Qiang Wang, MD, Yinglong Liu, MD, Ming Du, MD, Xiangdong.
Simvastatin Increases Neutrophil Apoptosis and Reduces Inflammatory Reaction After Coronary Surgery  Massimo Chello, MD, Amedeo Anselmi, MD, Cristiano.
Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD 
Oxidative Stress and Atrial Fibrillation After Cardiac Surgery: A Case-Control Study  Basel Ramlawi, MD, MMSc, Hasan Otu, PhD, Shigetoshi Mieno, MD, Munir.
Amedeo Anselmi, MD, Gianfederico Possati, MD, Mario Gaudino, MD 
Definition of postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass: One size doesn't fit all  David Faraoni, MD,
Synergistic Immunosuppression Caused by High-Dose Methylprednisolone and Cardiopulmonary Bypass  Hisanori Mayumi, MD, Qui-Wei Zhang, MD, Atsuhiro Nakashima,
An Analysis of Oxygen Consumption and Oxygen Delivery in Euthermic Infants After Cardiopulmonary Bypass With Modified Ultrafiltration  Jia Li, MD, PhD,
John Alfred Carr, MD, Joseph J. Amato, MD, Robert S.D. Higgins, MD 
William T. Mahle, MD, Emilia Matthews, MS, Kirk R. Kanter, MD, Brian E
Influence of Mechanical Cell Salvage on Red Blood Cell Aggregation, Deformability, and 2,3-Diphosphoglycerate in Patients Undergoing Cardiac Surgery With.
Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery  John L Francis, PhD, George J Palmer, MD, Rebecca Moroose,
Who Do You Say You Are? The Annals of Thoracic Surgery
Delayed Presentation of Nitroprusside-Induced Cyanide Toxicity
Relationship Between Antiinflammatory Cytokine Interleukin-10 and Lactate Concentrations in Neonates Undergoing the Arterial Switch Operation  Kyrylo.
Use of Recombinant Activated Factor VII Concentrate to Control Postoperative Hemorrhage in Complex Cardiovascular Surgery  Lyndsey J. Bowman, Walter E.
Damien J. LaPar, MD, MS, James M. Isbell, MD, MSCI, Daniel P
Comparative effects of propofol versus fentanyl on cerebral oxygenation state during normothermic cardiopulmonary bypass and postoperative cognitive dysfunction 
Clinical performance and biocompatibility of poly(2-methoxyethylacrylate)—coated extracorporeal circuits  Serdar Gunaydin, MD, Bora Farsak, MD, Mustafa.
Risks and Predictors of Blood Transfusion in Pediatric Patients Undergoing Open Heart Operations  Andrea Székely, MD, PhD, Zsuzsanna Cserép, MD, Erzsébet.
Antithrombin Administration in Patients With Low Antithrombin Values After Cardiac Surgery: A Randomized Controlled Trial  Domenico Paparella, MD, Crescenzia.
Minimized Cardiopulmonary Bypass Reduces Retinal Microembolization: A Randomized Clinical Study Using Fluorescein Angiography  Riikka Rimpiläinen, MD,
Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response  Martin Westerberg, MD, Anders.
Serum C-Reactive Protein as a Predictor of Morbidity and Mortality in Intensive Care Unit Patients After Esophagectomy  Michel E. van Genderen, BS, Alexandre.
Michael J. Wolf, MD, Kirk R. Kanter, MD, Paul M. Kirshbom, MD, Brian E
The effects of normoxic versus hyperoxic cardiopulmonary bypass on oxidative stress and inflammatory response in cyanotic pediatric patients undergoing.
Bradford B. Smith, MD, Matthew A
Red Blood Cell Transfusion Is Associated With Troponin Release After Elective Off- Pump Coronary Artery Bypass Surgery  Fausto Biancari, MD, PhD, Eeva-Maija.
Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor
Cardiac surgery with deep hypothermic circulatory arrest produces less systemic inflammatory response than low-flow cardiopulmonary bypass in newborns 
Sune Damgaard, MD, PhD, Claus H. Nielsen, MD, PhD, Lars W
Time course of proinflammatory and anti-inflammatory responses after cardiac operation: monocyte HLA-DR expression  Y.John Gu, MD, PhD, Willem van Oeveren,
Preoperative Intraaortic Balloon Pump Enhances Cardiac Performance and Improves the Outcome of Redo CABG  Jan T. Christenson, MD, PhD, Pierre Badel, MD,
Robert Lee Replogle, September 30, 1931–May 9, 2016
Randomized Controlled Trial of Pericardial Blood Processing With a Cell-Saving Device on Neurologic Markers in Elderly Patients Undergoing Coronary Artery.
Reduced inotropic support after aprotinin therapy during pediatric cardiac operations  Carl F Wippermann, MD, Franz X Schmid, MD, Balthasar Eberle, MD,
Prospective Validation of a Novel Vasoactive-Ventilation-Renal Score as a Predictor of Outcomes After Pediatric Cardiac Surgery  Kyle G. Miletic, MD,
Induction of Interleukin-19 and Interleukin-22 After Cardiac Surgery With Cardiopulmonary Bypass  Chung-Hsi Hsing, MD, Mei-Yi Hsieh, MS, Wei-Yu Chen,
Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient 
Impact of Preoperative Anemia on Outcome in Adult Cardiac Surgery: A Propensity- Matched Analysis  Marco Ranucci, MD, FESC, Umberto Di Dedda, MD, Serenella.
An Assay to Monitor Bivalirudin Levels on Cardiopulmonary Bypass
The Impact of New Technology on Cardiothoracic Surgical Practice
Reduced Cytokines Release and Myocardial Damage in Coronary Artery Bypass Patients Due to L-Arginine Cardioplegia Supplementation  Luisa Colagrande, MD,
Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD 
Leukocytosis and Increased Risk of Atrial Fibrillation After General Thoracic Surgery  David Amar, MD, Anuj Goenka, BS, Hao Zhang, MD, Bernard Park, MD,
Karl A. Bocchieri, BS, CCP, S. Jacob Scheinerman, MD, L
Stephen Greer, MD, Ashley D. Miller, FNP, Jeremiah S
Thrombophilic Variables Do Not Increase the Generation or Procoagulant Activity of Thrombin During Cardiopulmonary Bypass  Peter Raivio, MD, Jari Petäjä,
Presentation transcript:

Stress-Dose Corticosteroid Versus Placebo in Neonatal Cardiac Operations: A Randomized Controlled Trial  Pertti K. Suominen, MD, PhD, Juho Keski-Nisula, MD, Tiina Ojala, MD, PhD, Paula Rautiainen, MD, PhD, Timo Jahnukainen, MD, PhD, Johanna Hästbacka, MD, PhD, Pertti J. Neuvonen, MD, PhD, Olli Pitkänen, MD, PhD, Jussi Niemelä, MD, PhD, Anu Kaskinen, MD, Jukka Salminen, MD, PhD, Risto Lapatto, MD, PhD  The Annals of Thoracic Surgery  Volume 104, Issue 4, Pages 1378-1385 (October 2017) DOI: 10.1016/j.athoracsur.2017.01.111 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 The mean ± SD plasma concentrations of (A) interleukin (IL)-6, (B) IL-10, (C) C-reactive protein (CRP), and (D) white blood cell count collected preoperatively (T1), at 0 (T2) and 6 (T3) hours after cardiopulmonary bypass, and during postoperative days 1 to 5 (T4 to 8) in the stress-dose corticosteroid (SDC) and placebo groups. *p < 0.05 and **p < 0.001 indicate a significant difference between the groups. The Annals of Thoracic Surgery 2017 104, 1378-1385DOI: (10.1016/j.athoracsur.2017.01.111) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 The (A) inotropic score, (B) plasma lactate, and (C) central venous saturation (Svo2) values (means ± SD) in the stress-dose corticosteroid (SDC) and placebo groups on the pediatric intensive care unit (PICU) arrival, 6 hours after cessation of cardiopulmonary bypass (CPB), and on postoperative days (PODs) 1 to 6. ∗p < 0.05 and ∗∗p < 0.001 indicate a significant difference between the study groups. The Annals of Thoracic Surgery 2017 104, 1378-1385DOI: (10.1016/j.athoracsur.2017.01.111) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Plasma concentrations (means ± SD) of methylprednisolone in 20 neonates in the stress-dose corticosteroid group (SDC) undergoing cardiac operations after the intravenous administration of methylprednisolone (2 mg/kg). The time points: T1, after induction of anesthesia; T2, after weaning from cardiopulmonary bypass (CBP); T3, 6 hours after cessation of CPB; and T4, at the first postoperative morning. The Annals of Thoracic Surgery 2017 104, 1378-1385DOI: (10.1016/j.athoracsur.2017.01.111) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Plasma cortisol concentrations (means ± SD) in neonates receiving stress-dose cortisone (SDC; n = 20) or placebo (n = 20) intraoperatively and postoperatively. The time-points: T1, after induction of anesthesia; T2, after weaning from cardiopulmonary bypass (CBP); T3, 6 hours after cessation of CPB; and T4 to T8, in the following 5 postoperative days. The Annals of Thoracic Surgery 2017 104, 1378-1385DOI: (10.1016/j.athoracsur.2017.01.111) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions